January 4, 2018 Acad, Gov/Utilities Bio/Pharma/CRO Clinical Research/Diagn. Environ, Ag./Food & Bev Life Science Tools M&A, Partnerships

Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a starting point to deliver... Read more

January 3, 2018 Clinical Research/Diagn.

Seegene develops world’s first multiplex MDx assays with its AI system

Seoul, South Korea – Jan 3, 2018 – Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, announced today that, utilizing a newly created artificial intelligence (“AI”) based assay development system, the company succeeded in developing molecular diagnostics (“MDx”) assays in only four (4) days. These assays are high multiplex... Read more

December 21, 2017 Clinical Research/Diagn.

Announcement on investigator-initiated clinical trial of neoadjuvant combination therapy with HF10 and Nivolumab

Announcement on investigator-initiated clinical trial of neoadjuvant combination therapy with HF10 and Nivolumab Announcement on investigator-initiated clinical trial of neoadjuvant combination therapy with HF10 and Nivolumab Kusatsu Shiga, Japan―December 21 , 2017― Takara Bio Inc. (Takara Bio) announced today it has entered into an agreement with Huntsman Cancer Institute (HCI) at the University of Utah... Read more

December 20, 2017 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership

Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership WALTHAM, Mass., Dec. 20, 2017 /PRNewswire/ — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T)... Read more

December 18, 2017 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

First Genomic Platform Powered by the Blockchain Raises $2 Million in Funding; Backed by Illumina Veterans

Luna DNA is the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community. SAN DIEGO, Dec. 18, 2017 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced $2 Million in Seed funding today. The round included... Read more

December 5, 2017 Acad, Gov/Utilities Clinical Research/Diagn.

TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) FDA partial clinical hold lifted

Basel, 05 December 2017 TECENTRIQ GO29695 (NCT02431208) and BO29562 (NCT02631577) FDA partial clinical hold lifted Roche (SIX: RO, ROG; OTCQX: RHHBY): today announced that following close consultation and agreement on study modifications with the U.S. Food and Drug Administration (FDA), the partial clinical holds placed on the Phase Ib and Phase Ib/II studies evaluating TECENTRIQ... Read more

December 4, 2017 Acad, Gov/Utilities Clinical Research/Diagn.

FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

Basel, 04 December 2017 FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved FoundationOne CDx™, Foundation Medicine’s comprehensive companion diagnostic assay for personalised oncology care1. FoundationOne... Read more

November 28, 2017 Clinical Research/Diagn. Life Science Tools PR/Corporate

Bio-Rad Authorizes New $250 Million Share Repurchase Program

HERCULES, Calif — November 28, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that its board of directors has authorized a new share repurchase program, granting the Company authority to repurchase, on a discretionary basis, up to $250 million of the outstanding... Read more

November 21, 2017 Acad, Gov/Utilities Chromatography Clinical Research/Diagn. Environ, Ag./Food & Bev Lab Top-10 Licensing, IP, and Legal

Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha Health plc, et al. and the patent infringement suit filed against Ariosa Diagnostics, Inc., et al. The Court found... Read more